The clinico-pathologic role of MicroRNAs miR-9 and miR-151-5p in breast cancer metastasis

Molecular Diagnosis and Therapy

Volumn 16, Issue 3, 2012, Pages 167-172

  Krell, Jonathan ^a   Frampton, Adam E ^b   Jacob, Jimmy ^a   Pellegrino, Loredana ^a   Roca Alonso, Laura ^a   Zeloof, Daniel ^c   Alifrangis, Costi ^c   Lewis, Jacqueline S ^c   Jiao, Long R ^b   Stebbing, Justin ^c   Castellano, Leandro ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Breast cancer; MicroRNAs

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 151 5P; MICRORNA 9; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84861701627     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03262205     Document Type: Article

References (31)

1. Gupta GP, Massague J. Cancer metastasis: Building a framework. Cell 2006 Nov 17; 127 (4): 679-95
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002 Jun; 2 (6): 442-54
3. Fidler IJ. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003 Jun; 3 (6): 453-8
4. Ma L, Weinberg RA. Micromanagers of malignancy: Role of microRNAs in regulating metastasis. Trends Genet 2008 Sep; 24 (9): 448-56
5. Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs: The micro steering wheel of tumour metastases. Nat Rev Cancer 2009 Apr; 9 (4): 293-302
6. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004 Jan 23; 116 (2): 281-97
7. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009 Jan 23; 136 (2): 215-33
8. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004 Mar 2; 101 (9): 2999-3004
9. Ventura A, Jacks T. MicroRNAs and cancer: Short RNAs go a long way. Cell 2009 Feb 20; 136 (4): 586-91
10. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006 Nov; 6 (11): 857-66
11. Castellano L, Giamas G, Jacob J, et al. The estrogen receptor-Alpha- induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 2009 Sep 15; 106 (37): 15732-7
12. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007 Oct 11; 449 (7163): 682-8
13. Iorio MV, Ferracin M, Liu CG, et al. MicroRNAgene expression deregulation in human breast cancer. Cancer Res 2005 Aug 15; 65 (16): 7065-7070
14. Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-Activated micro-RNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010 Mar; 12 (3): 247-56
15. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008 Jan 10; 451 (7175): 147-52
16. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009 Jun 12; 137 (6): 1032-1046
17. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008 Sep 9; 105 (36): 13556-61
18. Luedde T. MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology 2010 Sep; 52 (3): 1164-6
19. Loudig O, Milova E, Brandwein-Gensler M, et al. Molecular restoration of archived transcriptional profiles by complementary-template reversetranscription (CT-RT). Nucleic Acids Res 2007; 35 (15): E94
20. Enerly E, Steinfeld I, KleiviK, et al. miRNA-mRNAintegrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011; 6 (2): E16915
21. Buffa FM, Camps C, Winchester L, et al. microRNA-Associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 2011 Sep 1; 71 (17): 5635-5645
22. Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic cancer [abstract]. J Clin Oncol 2011 Feb 1; 29 (4 Suppl.): Abstract 153
23. Finak G, Bertos N, Pepin F, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14 (5): 518-27
24. Walker RA, Bartlett JM, Dowsett M, et al. HER2 testing in the UK: Further update to recommendations. J Clin Pathol 2008 Jul; 61 (7): 818-24
25. Sieuwerts AM, Mostert B, Bolt-de Vries J, et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 2011 Jun 1; 17 (11): 3600-3618
26. Shaw JA, Brown J, Coombes RC, et al. Circulating tumor cells and plasma DNAanalysis in patients with indeterminate early or metastatic breast cancer. Biomark Med 2011 Feb; 5 (1): 87-91
27. Gu Y, Lin S, Li JL, et al. Altered LKB1/CREB-regulated transcription coactivator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 2012 Jan 26; 31 (4): 469-79
28. Tognon CE, Somasiri AM, Evdokimova VE, et al. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res 2011 Feb 1; 71 (3): 1060-1070
29. Wendt MK, Schiemann WP. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res 2009; 11 (5): R68
30. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001 Jan; 115 (1): 85-98
31. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993 Apr; 142 (4): 987-93